Search Results

There are 2307 results for: content related to: Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer

  1. Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways

    Molecular Carcinogenesis

    Volume 52, Issue 3, March 2013, Pages: 183–194, Tsung-Ying Yang, Gee-Chen Chang, Kun-Chieh Chen, Hsiao-Wen Hung, Kuo-Hsuan Hsu, Chi-Hao Wu, Gwo-Tarng Sheu and Shih-Lan Hsu

    Version of Record online : 15 NOV 2011, DOI: 10.1002/mc.21842

  2. Pemetrexed, a Novel Antifolate Therapeutic Alternative for Cancer Chemotherapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 5, May 2006, Pages: 641–654, Leticia R. Villela, Brad L. Stanford and Dr. Sachin R. Shah

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.5.641

  3. You have free access to this content
    Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer


    Volume 121, Issue 6, March 15, 2015, Pages: 883–892, Robert C. Doebele, David Spigel, Mustapha Tehfe, Sachdev Thomas, Martin Reck, Sunil Verma, Janice Eakle, Frederique Bustin, Jerome Goldschmidt Jr, Dachuang Cao, Ekaterine Alexandris, Sergey Yurasov, D. Ross Camidge and Philip Bonomi

    Version of Record online : 6 NOV 2014, DOI: 10.1002/cncr.29132

  4. You have free access to this content
    Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer


    Volume 118, Issue 19, 1 October 2012, Pages: 4694–4705, Susan Urba, Carla M. L. van Herpen, Tarini Prasad Sahoo, Dong M. Shin, Lisa Licitra, Klara Mezei, Christoph Reuter, Ricardo Hitt, Francesca Russo, Shao-Chun Chang, Anwar M. Hossain, Bente Frimodt-Moller, Andrew Koustenis and Ruey-Long Hong

    Version of Record online : 20 MAR 2012, DOI: 10.1002/cncr.27449

  5. You have full text access to this Open Access content
    Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study

    Thoracic Cancer

    Volume 5, Issue 5, September 2014, Pages: 365–376, Chengping Hu, Yan Wang, Jianhua Chen, Shengqi Wu, Xiaoling Li, Yuqin Wang, Yicheng Yang, Narayan Rajan, Manny Papadimitropoulos, Qiong Xiao, Huan Zhan and Wendong Chen

    Version of Record online : 25 AUG 2014, DOI: 10.1111/1759-7714.12102

  6. Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 4, December 2010, Pages: 350–356, Arman HASANI, Kynan FEENEY, Anna NOWAK and Michael MILLWARD

    Version of Record online : 27 JUL 2010, DOI: 10.1111/j.1743-7563.2010.01316.x

  7. Prediction of Neutropenia-Related Effects of a New Combination Therapy With the Anticancer Drugs BI 2536 (a Plk1 Inhibitor) and Pemetrexed

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 660–667, E Soto, A Staab, M Freiwald, G Munzert, H Fritsch, C Döge and I F Trocóniz

    Version of Record online : 6 OCT 2010, DOI: 10.1038/clpt.2010.148

  8. You have full text access to this Open Access content
    Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

    Cancer Science

    Volume 101, Issue 1, January 2010, Pages: 161–166, Hiroaki Ozasa, Tetsuya Oguri, Takehiro Uemura, Mikinori Miyazaki, Ken Maeno, Shigeki Sato and Ryuzo Ueda

    Version of Record online : 10 SEP 2009, DOI: 10.1111/j.1349-7006.2009.01358.x

  9. You have free access to this content
    Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01)


    Volume 118, Issue 24, 15 December 2012, Pages: 6234–6242, Jong-Mu Sun, Ki Hyeong Lee, Sang-we Kim, Dae Ho Lee, Young Joo Min, Hwan Jung Yun, Hoon Kyo Kim, Hong Suk Song, Yeul Hong Kim, Bong-Seog Kim, In Gyu Hwang, Keehyun Lee, Sook Jung Jo, Jae Won Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn and for the Korean Cancer Study Group (KCSG)

    Version of Record online : 6 JUN 2012, DOI: 10.1002/cncr.27630

  10. You have full text access to this Open Access content
    Cytotoxic effects of pemetrexed in gastric cancer cells

    Cancer Science

    Volume 96, Issue 6, June 2005, Pages: 365–371, Jee Hyun Kim, Keun-Wook Lee, Yeonjoo Jung, Tai Young Kim, Hye Seon Ham, Hyun-Soon Jong, Kyung Hae Jung, Seock-Ah Im, Tae-You Kim, Noe Kyeong Kim and Yung-Jue Bang

    Version of Record online : 15 JUN 2005, DOI: 10.1111/j.1349-7006.2005.00058.x

  11. You have free access to this content
    SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma

    International Journal of Cancer

    Volume 132, Issue 2, 15 January 2013, Pages: 459–471, Kota Iwahori, Satoshi Serada, Minoru Fujimoto, Barry Ripley, Shintaro Nomura, Hiroyuki Mizuguchi, Kazuki Shimada, Tsuyoshi Takahashi, Ichiro Kawase, Tadamitsu Kishimoto and Tetsuji Naka

    Version of Record online : 17 MAY 2012, DOI: 10.1002/ijc.27611

  12. Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study

    Pediatric Blood & Cancer

    Volume 60, Issue 2, February 2013, Pages: 237–241, Anne B. Warwick, Suman Malempati, Mark Krailo, Allen Melemed, Richard Gorlick, Matthew M. Ames, Stephanie L. Safgren, Peter C. Adamson and Susan M. Blaney

    Version of Record online : 28 JUN 2012, DOI: 10.1002/pbc.24244

  13. You have full text access to this Open Access content
    Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan

    Thoracic Cancer

    Volume 5, Issue 4, July 2014, Pages: 289–296, Kazuhiro Asami, Masaaki Kawahara, Tomonori Hirashima, Hidekazu Suzuki, Kyoichi Okishio, Naoki Omachi, Motohiro Tamiya, Akihiro Tamiya, Aya Hirooka, Keiko Nakao, Taisuke Tsuji and Shinji Atagi

    Version of Record online : 3 JUL 2014, DOI: 10.1111/1759-7714.12091

  14. Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma

    Intervention Review

    The Cochrane Library

    John A Green, Yenal Dundar, Susanna R Dodd, Rumona C Dickson and Tom Walley

    Published Online : 24 JAN 2007, DOI: 10.1002/14651858.CD005574.pub2

  15. You have free access to this content
    Review of a promising new agent—pemetrexed disodium


    Volume 97, Issue S8, 15 April 2003, Pages: 2056–2063, Luis Paz-Ares, Susana Bezares, José M. Tabernero, Daniel Castellanos and Hernán Cortes-Funes

    Version of Record online : 1 APR 2003, DOI: 10.1002/cncr.11279

  16. You have free access to this content
    Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer

    International Journal of Cancer

    Volume 130, Issue 8, 15 April 2012, Pages: 1777–1786, Paolo Ceppi, Ida Rapa, Marco Lo Iacono, Luisella Righi, Jessica Giorcelli, Marisa Pautasso, Andrea Billè, Francesco Ardissone, Mauro Papotti and Giorgio V. Scagliotti

    Version of Record online : 5 AUG 2011, DOI: 10.1002/ijc.26188

  17. You have full text access to this OnlineOpen article
    Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3

    Cancer Science

    Volume 106, Issue 9, September 2015, Pages: 1202–1211, Terufumi Kato, Hiroshige Yoshioka, Isamu Okamoto, Akira Yokoyama, Toyoaki Hida, Takashi Seto, Katsuyuki Kiura, Dan Massey, Yoko Seki and Nobuyuki Yamamoto

    Version of Record online : 25 JUL 2015, DOI: 10.1111/cas.12723

  18. You have free access to this content
    Pemetrexed in malignant pleural mesothelioma and the clinical outcome

    The Clinical Respiratory Journal

    Volume 6, Issue 2, April 2012, Pages: 96–103, Aija Knuuttila, Eija-Riitta Salomaa, Suvi Saikkonen, Saija Hurme and Jarmo Salo

    Version of Record online : 6 JUL 2011, DOI: 10.1111/j.1752-699X.2011.00252.x

  19. You have free access to this content
    Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice

    Value in Health

    Volume 11, Issue 1, January/February 2008, Pages: 4–12, Anna Cordony, Corinne Le Reun, Antje Smala, James T. Symanowski and Jessamy Watkins

    Version of Record online : 25 JUN 2007, DOI: 10.1111/j.1524-4733.2007.00209.x

  20. Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue s2, June 2011, Pages: 34–40, Gee-Chen CHANG, Myung-Ju AHN, Elaine WRIGHT, Heung Tae KIM, Joo-Hang KIM, Jin Hyoung KANG, Sang-We KIM, Steven SHERMAN and Stefan WALZER

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1743-7563.2011.01400.x